跳至主要内容
临床试验/ISRCTN47698087
ISRCTN47698087已完成未知

Behavioural and neuroimaging effects of stress, habits and attachment in obsessive-compulsive disorder (SHA-OCD)

Zon MW0 个研究点目标入组 46 人开始时间: 2019年2月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32094333/ (added 27/03/2023)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Diagnosis of OCD with obsessions and compulsions assessed with the MINI Neuropsychiatric Interview (MINI)
  • 2. Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) score cut-off of 12
  • 3. 18-65 years of age
  • 4. Willingness and ability to give written informed consent and willingness and ability to understand, to participate and to comply with the study requirements
  • 1. 18-65 years of age
  • 2. Willingness and ability to give written informed consent and willingness and ability to understand, to participate and to comply with the study requirements

排除标准

  • 1. Current major depressive disorder, bipolar disorder, psychotic disorder, alcohol or substance dependence, or any cognitive disorder as assessed with the MINI
  • 2. Major head trauma or neurological disease, current or in history
  • 3. MRI contraindications such as metal implants, claustrophobia, left-handedness, pregnancy
  • 4. Self-reported inability or unease to cease smoking for 3 hours prior to testing
  • 5. Endocrinological disorders or regular use of corticosteroids
  • 6. Current treatment with antipsychotic medication
  • 7. Use of other psychotropic medication (apart from SSRI's or tricyclic antidepressant), or of recreational drugs over a period of 72 hours prior to each test session, and use of alcohol within the last 24 hours before each measurement
  • 8. Irregular sleep/wake rhythm (e.g., regular nightshifts or cross timeline travel).
  • 1. Current or past psychiatric diagnosis as assessed with the MINI
  • 2. Major head trauma or neurological disease, current or in history
  • 3. MRI contraindications such as metal implants, claustrophobia, pregnancy
  • 4. Self-reported inability or unease to cease smoking for 24 hours prior to testing
  • 5. Endocrinological disorders or regular use of corticosteroids
  • 6. Use of psychotropic medication, or of recreational drugs over a period of 72 hours prior to each test session, and use of alcohol within the last 24 hours before each measurement
  • 7. Irregular sleep/wake rhythm (e.g., regular nightshifts or cross timeline travel).

研究者

发起方
Zon MW

相似试验